News
0
Gilead will allow generic manufacturers to produce medicine targeting all genotypes of hepatitis C
0
FDA fast-tracks Hunter syndrome treatment and approves newly-acquired NPS Pharma’s Natpara
0
Watchdog gives final draft guidance in another blood clot indication for Xarelto
0
Swiss pharma giant wins recommendations for blood cancer drug and meningitis B vaccine
Features
The acting deputy chief pharmaceutical officer at NHS England talks to Pharmafile
Featured Appointment
Cipher Pharmaceuticals has appointed Lynne Bulger as vice president of its medical and clinical affairs whilst...
